COVID‐19 Outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: A US multicenter, comparative cohort study
This study (n=145129) found patients with there candidates had significantly higher risk of hospitalisation (RR 1.14 [95% CI 1.03–1.26], ICU admission (RR 1.32 [95% CI 1.03–1.68]), acute renal failure (RR 1.81 [95% CI 1.07–3.07]), and VTE (RR 1.74 [95% CI 1.23–2.45])
Source:
Arthritis & Rheumatology